Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (181-190 of 411) with videos related to

Pageof 42
Sort By:
Journal of Alzheimer'S Disease : JAD|June 30, 2025
Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhoodJoão Areias Saraiva, Martin Becker, Martin Dyrba, et al.
Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.
Neuropharmacology|February 16, 2016
Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's diseaseStefan J Teipel, Enrica Cavedo, Michel J Grothe, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2003
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot studyMetin Bagli, Andreas Papassotiropoulos, Harald Hampel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2002
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensityFrank Padberg, Peter Zwanzger, Martin E Keck, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 30, 2002
High-resolution peptide mapping of cerebrospinal fluid: a novel concept for diagnosis and research in central nervous system diseasesGabriele Heine, Hans Dieter Zucht, Martin U Schuhmann, et al.
Neuroimage|December 15, 2006
Multivariate network analysis of fiber tract integrity in Alzheimer's diseaseStefan J Teipel, Robert Stahl, Olaf Dietrich, et al.
Schizophrenia Research|July 24, 2012
Association between white matter fiber integrity and subclinical psychotic symptoms in schizophrenia patients and unaffected relativesChristian Knöchel, Laurence O'Dwyer, Gilberto Alves, et al.
Nature Neuroscience|June 19, 2024
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathwaySneha Narasimhan, David M Holtzman, Liana G Apostolova, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairmentKatharina Buerger, Olga Uspenskaya, Oliver Hartmann, et al.
Pageof 42

Showing results (181-190 of 411) with videos related to

Sort By:
Pageof 42
Journal of Alzheimer'S Disease : JAD|June 30, 2025
Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhoodJoão Areias Saraiva, Martin Becker, Martin Dyrba, et al.
Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.
Neuropharmacology|February 16, 2016
Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's diseaseStefan J Teipel, Enrica Cavedo, Michel J Grothe, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2003
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot studyMetin Bagli, Andreas Papassotiropoulos, Harald Hampel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2002
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensityFrank Padberg, Peter Zwanzger, Martin E Keck, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 30, 2002
High-resolution peptide mapping of cerebrospinal fluid: a novel concept for diagnosis and research in central nervous system diseasesGabriele Heine, Hans Dieter Zucht, Martin U Schuhmann, et al.
Neuroimage|December 15, 2006
Multivariate network analysis of fiber tract integrity in Alzheimer's diseaseStefan J Teipel, Robert Stahl, Olaf Dietrich, et al.
Schizophrenia Research|July 24, 2012
Association between white matter fiber integrity and subclinical psychotic symptoms in schizophrenia patients and unaffected relativesChristian Knöchel, Laurence O'Dwyer, Gilberto Alves, et al.
Nature Neuroscience|June 19, 2024
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathwaySneha Narasimhan, David M Holtzman, Liana G Apostolova, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairmentKatharina Buerger, Olga Uspenskaya, Oliver Hartmann, et al.
Pageof 42